Loading…

A microfluidic chip for capturing, imaging and counting CD3+ T-lymphocytes and CD19+ B-lymphocytes from whole blood

•We propose a pillar-based microfluidic device to separate leukocytes from whole blood high efficiently without clogging.•We could obtain the count and ratio of T and B cells from whole blood and compared the results to those obtained using a flow cytometer.•We achieved 99.8% efficiency in capturing...

Full description

Saved in:
Bibliographic Details
Published in:Sensors and actuators. B, Chemical Chemical, 2018-12, Vol.276, p.107-113
Main Authors: Mohd Noor, Anas, Masuda, Taisuke, Lei, Wu, Horio, Koji, Miyata, Yasuhiko, Namatame, Miyuki, Hayase, Yoko, Saito, Toshiki I., Arai, Fumihito
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•We propose a pillar-based microfluidic device to separate leukocytes from whole blood high efficiently without clogging.•We could obtain the count and ratio of T and B cells from whole blood and compared the results to those obtained using a flow cytometer.•We achieved 99.8% efficiency in capturing leukocytes using the microfluidic chip,•The ratio of CD3+ and CD19+ had a coefficient of r = 0.9876 and a coefficient of variation of 2.77%, from 1 μL of whole blood sample. We have designed and evaluated a simple and practical system for CD3+ (T-lymphocyte) and CD19+ (B-lymphocyte) cell counting on-chip using a PDMS microfluidic chip which captures these cells using a pillarbased filtration technique. Conventional pillar-based or membrane-based cell separation methods suffer from the problem of cell clogging, thereby reducing the separating and capturing efficiency of the device. To address these issues, we proposed a unique and simple design of a microfluidic chip with an escape route at the pillar-based cell filtration area in the chip which prevents cell clogging. Currently, the diagnosis, monitoring and treatment of immunodeficiency disorder require quantifying the leukocyte population, especially T-lymphocytes and Blymphocytes, in whole blood. We evaluated the performance of our microfluidic chip by obtaining the ratio of T-lymphocytes and Blymphocytes from whole blood and compared the results to those obtained using a flow cytometer. We confirmed that the cell capture area of the microfluidic chip remains clog-free. We achieved 99.8% efficiency in capturing leukocytes using the microfluidic chip, and the ratio of CD3+ and CD19+ had a coefficient of r = 0.9876 and a coefficient of variation (CV) of 2.77%, from 1 μL of whole blood sample.
ISSN:0925-4005
1873-3077
DOI:10.1016/j.snb.2018.08.063